Both in Pharmaceuticals
Citius Pharmaceuticals vs Biofrontera
Over the past year CTXR returned −62.3% and BFRI returned −19.1%; their daily moves had a correlation of 0.11.
CTXR −62.3% BFRI −19.1%Growth of $1, one year, split-adjusted
| Metric | CTXR | BFRI |
|---|---|---|
| Price | $0.5732 | $0.8899 |
| Market cap | $15.7M | $13.2M |
| Today | +1.99% | +2.28% |
| 1 month | +10.2% | −0.1% |
| 6 months | −16.6% | −22.6% |
| Year to date | −26.2% | +56.1% |
| 1 year | −63.7% | −19.1% |
| Revenue growth (YoY) | — | +32.9% |
| Gross margin | 67.1% | 79.9% |
| Net margin | −593.3% | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | 0.3× |
| Net cash | $10.6M | $47.0K |
| Dividend yield | — | — |
| Volatility (60d) | 96.6% | 75.9% |
| Short % of float | 21.9% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).